First FDA-approved Treatment for Rare Form of Non-Hodgkin Lymphoma
Last week, the U.S. Food and Drug Administration (FDA) announced the first-ever approval of a treatment for Waldenström macroglobulinemia,...
Last week, the U.S. Food and Drug Administration (FDA) announced the first-ever approval of a treatment for Waldenström macroglobulinemia,...
Researchers at Weill Cornell Medical College have identified a mutation that may be responsible in mantle cell lymphoma for...